Prisoner May Amend Zyprexa Claims, Judge Rules

SACRAMENTO, Calif. - A state prisoner who alleges that his diabetes was caused by Zyprexa failed to sufficiently plead a state law products liability claim against Eli Lilly Co., a California federal judge has ruled. Singleton v. Eli Lilly Co., No. 10-2019 (E.D. Calif.).

On Jan. 28, Magistrate Judge Sheila K. Oberto of the U.S. District Court for the Eastern District of California granted the plaintiff leave to amend his complaint to cure its multiple deficiencies.

In October 2010, LaMar Singleton, a state prisoner proceeding in forma pauperis, sued Eli Lilly Co., alleging that his ingestion of Zyprexa caused him …